We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Rules Apotex Must Pay $551 Million for Generic Plavix Launch
Judge Rules Apotex Must Pay $551 Million for Generic Plavix Launch
October 22, 2010
Apotex’s 2006 decision to sell a generic version of Sanofi-Aventis/Bristol-Myers Squibb’s blood thinner Plavix will cost the Canadian drugmaker $551 million, a federal judge ordered Oct. 19.